{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:42:42Z","timestamp":1789040562405,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/inf.0000000000000995","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T12:57:44Z","timestamp":1447505864000},"page":"292-296","source":"Crossref","is-referenced-by-count":26,"title":["Pneumococcal Mastoiditis in Children Before and After the Introduction of Conjugate Pneumococcal Vaccines"],"prefix":"10.1097","volume":"35","author":[{"given":"Emmanouil I.","family":"Koutouzis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Michos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini I.","family":"Koutouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Chatzichristou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Parpounas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Georgaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Theodoridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki P.","family":"Syriopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210202","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0009922809344349","article-title":"Clinical strategies for the management of acute mastoiditis in the pediatric population.","volume":"49","author":"Lin","year":"2010","journal-title":"Clin Pediatr (Phila)"},{"key":"R2-13-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00365548.2013.849814","article-title":"Changes in acute mastoiditis in a single pediatric tertiary medical center: our experience during 2008-2009 compared with data for 1983-2007.","volume":"46","author":"Amir","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"R3-13-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R4-13-20210202","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/civ067","article-title":"Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era.","volume":"60","author":"Kaplan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R5-13-20210202","doi-asserted-by":"crossref","first-page":"e54333","DOI":"10.1371\/journal.pone.0054333","article-title":"Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain.","volume":"8","author":"Alonso","year":"2013","journal-title":"PloS one"},{"key":"R6-13-20210202","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1542\/peds.2007-0619","article-title":"Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.","volume":"121","author":"Zhou","year":"2008","journal-title":"Pediatrics"},{"key":"R7-13-20210202","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0b013e3181c1bc48","article-title":"New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.","volume":"29","author":"Casey","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R8-13-20210202","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/INF.0b013e31821038d9","article-title":"The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea.","volume":"30","author":"Stamboulidis","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R9-13-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1542\/peds.2007-2703","article-title":"Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates.","volume":"122","author":"Ongkasuwan","year":"2008","journal-title":"Pediatrics"},{"key":"R10-13-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/INF.0000000000000138","article-title":"Incidence of acute mastoiditis in Colorado children in the pneumococcal conjugate vaccine era.","volume":"33","author":"Halgrimson","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R11-13-20210202","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/ciu683","article-title":"Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent13-valent PCV.","volume":"59","author":"Ben-Shimol","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R12-13-20210202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R13-13-20210202","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/48.6.915","article-title":"Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants.","volume":"48","author":"Nagai","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"R16-13-20210202","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/AAC.01487-07","article-title":"Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).","volume":"52","author":"de la Pedrosa","year":"2008","journal-title":"Antimicrob Agents chemother"},{"key":"R17-13-20210202","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by PCR.","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-13-20210202","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.diagmicrobio.2007.10.020","article-title":"Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.","volume":"60","author":"Daikos","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R19-13-20210202","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2334-12-255","article-title":"Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece.","volume":"12","author":"Grivea","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R20-13-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkt332","article-title":"Canadian Antimicrobial Resistance Alliance. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.","volume":"69","author":"Wierzbowski","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R21-13-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R22-13-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R23-13-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Finnish Otitis Media Study Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"R24-13-20210202","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.inf.0000253059.84602.c3","article-title":"Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.","volume":"26","author":"Farrell","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R25-13-20210202","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.","volume":"298","author":"Pichichero","year":"2007","journal-title":"JAMA"},{"key":"R27-13-20210202","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ijporl.2010.09.013","article-title":"Acute mastoiditis in children: a retrospective study of 188 patients.","volume":"74","author":"Quesnel","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R28-13-20210202","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archoto.2009.75","article-title":"Suppurative complications of acute otitis media: changes in frequency over time.","volume":"135","author":"Thorne","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R29-13-20210202","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/lary.21727","article-title":"Pediatric acute mastoiditis in the post-pneumococcal conjugate vaccine era.","volume":"121","author":"Choi","year":"2011","journal-title":"Laryngoscope"},{"key":"R30-13-20210202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/PEC.0b013e31815a0001","article-title":"Pediatric mastoiditis in the pneumococcal conjugate vaccine era: symptom duration guides empiric antimicrobial therapy.","volume":"23","author":"Roddy","year":"2007","journal-title":"Pediatr Emerg Care"},{"key":"R31-13-20210202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/INF.0b013e3182a6adb7","article-title":"Microbiology of acute mastoiditis and complicated or refractory acute otitis media among hospitalized children in the postvaccination era.","volume":"33","author":"Giannakopoulos","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R32-13-20210202","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijporl.2014.07.003","article-title":"Acute mastoiditis in children under 15 years of age in Southern Israel following the introduction of pneumococcal conjugate vaccines: a 4-year retrospective study (2009-2012).","volume":"78","author":"Kordeluk","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R33-13-20210202","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamapediatrics.2013.3924","article-title":"Trends in otitis media-related health care use in the United States, 2001-2011.","volume":"168","author":"Marom","year":"2014","journal-title":"JAMA Pediatr"},{"key":"R34-13-20210202","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/INF.0000000000000536","article-title":"Changing trends of acute otitis media bacteriology in central Israel in the pneumococcal conjugate vaccines era.","volume":"34","author":"Tamir","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R35-13-20210202","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/CVI.00289-14","article-title":"Acute mastoiditis in the pneumococcal conjugate vaccine era.","volume":"21","author":"Tamir","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"R36-13-20210202","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.ijporl.2012.08.018","article-title":"Development of pneumococcal mastoiditis due to multidrug-resistant serotype 19A despite three doses of 13-valent pneumococcal vaccine.","volume":"76","author":"Ruck","year":"2012","journal-title":"Int J Pediatr Otorhinolaryngol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T11:55:03Z","timestamp":1748692503000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201603000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000995","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}